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m1096102 MyocardiaiFlowReserveis ReducedversusNormalsin RegionsPerfusedbyCoronary
VesselsWithNon-criticaiStenosiswhichSupply
Collateral to otherZones
G. Holmvang,A.J. Fischman, H. Gewirlz. MassschusetLsGeneral Hoapita/,
Boaton, MA, USA
Myocardial flow reserve (MFR) in patients (Pts) with ischemic heart disease
may be reduced beth In collateral dependent myocerdium as well as in
segments (SEG) with non-critical stenosis. Since the need to provide blocd
flow to more than one vascular zone places an added demand on MFR
of the SUPPlY vessel, we tested the hypothesis that fIJFR is reduced in
SEG supplied by coronary arteries having non-critical stenosis (ie; < 70%
diameter reduction; caliper measure) which also give collaterals to other
SEG. Mathod Eight patients (6 male, age 64 & 6 yrs, mean+ SD) had PET
measurements of myocardial blood flow (MBF – ml/min/g; 13-NH3 method;
24 segment mcdel) at rest and with adenosine ((Ado) 140 pglkglmin). A Pt
based analysia was pertormed by averaging all SEG of each Pt which either
were in collateral dependent areas (CDA) and supplied by a vessels with
non-critical stenosis or were in the perfusion area of the vessel supplying
collaterals (CSV). MFR and MBF data were compared to a group of 11
normals (6 male, age 44 + 11yrs). MBF-see table.
Rest Ado-140 Ado/Rest
CDA 0,78 + 0.26 0.87 + 0.50 1.14 * 0.47
Csv’ 0.81 + 0.23 1.28 + 0.79” 1.52 + 0.89”
WNL 0.94 * 0.23 3.21 + 0.72”” 3.60 + 1.27**
*P <0.05, paired Pt based analysisCDA vs. CSV,**P <0.001, unpairedanalysisWNL
VS.CSV and CDA
Corrc/usion:MFR iswelibelownormal incollateral dependent myocardium
even if supply vessel has non-critical stenosis. MFR also is impaired sub-
stantially in myocsrdium in the perfusion area of a vessel with non-critical
stenosis supplying collaterals to other SEG. Thus, collaterals supporl rest
MBF but do not give adequate MFR in remote SEGS and also may decrease
MFR in SEGS of supply vessels with non-critical atenosis.
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~1097-72 I RiakFactOrsforVenousThr~mbosisinPatien*
withPermsnentTransvenousPacemakers
T. Ito, J. Tanouchi, Y. Wada, J. Kate, Y. Doi, M. Nishino, K. Iwai,
H. Tanahashi, Y. Yamada, T. Kamada. Oaeka Rosai Hospital, Osaka, Japan
THWWIOU8 endocardial pacing is currently the most common method of
permanent cardiac pacing, but venous thrombosis which may be caused by
the trensvenous pacing leads isa usual but occasionally serious complication
of permanent transvenous pacing. However, the pathogenesis has not been
defined. To elucidate risk factors for venous thrombosis in patients (pts) with
permanent transvenous pacemakers, we examine the relations of age, sex,
follow-up interval, site of implantation (right or left), type of pacemaker (DDD
or VVI) and type of arrhythmia to venous thromtmsis using multiple logistic
analysis in 74 pta with pacemakers who were not served with anticoagulant
or antiplatelet therapy. Digital subtraction ver’mgraphyand transesophageal
echoosrdicgrsphy were performed to evaluate the venous route thrombus in
all the study pte with pacemakers. 22 of 74 pts with pacemakers (29.7%) had
complicated venous route thrombosis.
Parameter Estimate P Odds Ratio
Acm 0.017 0.550 1.017.=.
Sex (male) 0.255 0.666 1.290
Follow-upinterval(yra) 0.034 0.713 1.035
Site of implantation(left) 0.247 0.713 1.280
Type of pscemaker(DDD) 1.961 0.007 7.103
Atrial fibrillation 1.832 0.022 6.248
DDD pacemaker, which ia originally considered to prevent thromboem-
bolism for physiological pacing, was a high risk factor of venous thrombosis,
probably due to stagnation caused by the pacing leads. We conclude that
DDD pacemaker end atrial fibrillation were risk factors forvenoua thrombosis
in pts with transvenous pacemakers, and these pts need careful observation.
m109773 MuiticenterTrialof AccurataHomeSelf-TestinginOralAnticoagulantPatientswitha NovelWhole
BioodSystem
R, Becker, M. Andrew, J. Ansell, D. Becker, D. Triplett, A. Shepherd.
Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, Canada,
Boston University Hospita/, Boston, MA, USA, University of Virginia Hea/th
Science CenteL Charf@fasville, VA, USA, University of Massachusetts
Medical Cente~ Worcestec MA, USA, Ball Memorial Hqpital, Muncie, IN,
USA, The Universltyof TexasHealth Science Gentec San Antonio, TX, USA
The study tested the accuracy of home monitoring as compared to the stan-
dard laboreto~ tests for patients receiving oral anticoagulants. Adults (n =
82) and children (n = 11), from multiple clinics in the US and Canada, were
trained to use the ProTime@Microcoagulation System (International Techni-
dyne Co., Edison, NJ) with a fingerstick sample. The ProTime@instrument
periorms five concomitant tests: 3 replicate PT and 2 mntrols. The study
Calledfor fingerstick seif-teating at home (HOME) with matched venous sam-
plea (VS) obtained in the local hospital within 3 hours of the HOME test, for
aix weeke. The VS was first tested with the ProTime@System and a aep-
arate sample sent to the local Iataratow (IAB) where the plasma test was
conducted (ISI ranged from 1.2 to 2.1). Aliquots of plaama were frozen and
shipped to a reference lab (REF) where it was tested (Ortho Recomboplastin
(ISI = 1.0), Ortho Diagnostics Raritan, NJ). Patient questionnaires graded
the ease of instrument use at home, and the preferred method of blood sam-
pling. No difference was detected between the ProTime@tests conducted at
HOME and in the local hospital (Student’s t test) and the results were highly
correlated (r = 0.92, n = 535). Patients were classified with respect to their
prescribed therapeutic ranges: (1) in range, (2) out of range-high, and (3)
out of range-low. LAB and HOME results were compared againat the REF
by therapeutic range classification. LAB and HOME equally predicted the
REF correctly (67.9% and 67.2%, respectively). Both test methods under-
estimated the REF classification (24.9% and 26.IYo) more frequently than
over-estimating the REF (7.2% and 6.7%). The correlation of HOME results
to MB by site ranged from r = 0.81 to r = 0.93 depending on the PT reagent
employed. Fingerstick sampling was the preferred method for 95% of the
participants. Overwhelmingly, patients graded the ProTime System easy to
use at home (85%). In conclusion, the ProTimen Microcoagulation System’
was easily used by patients for home PTtesting resulting in INR classification




N. Shinokawa, T. Hirai, S. Takaahima, Y. Hiraoka, T. Kameyama, H. Aaanoi,,
H. Inoue. ToyamaMedical and Pharmaceutical University Toyama,Japan
The purpose of this study was to investigate the predictive value of trans-
esophageal echocardiography (TEE) in the riak stratification of atherothrom-
botic orembolic cerebral infarction in patients with atrial fibrillation. Left atrial
spontaneous echo contrast (SEC), left atrial appendage peak flow velocity
(LAA-F) and generalized atherosclerosis as indicated by intima-media wall
thickness (lMT) of the thoracic aorta were assessed by TEE in 65 consec-
utive patients with paroxymal (n = 60) or chronic (n = 25) atrial fibrillation
(mean age; 83+ 11yre). All patients underwent brain CT or MR imaging to
evaluate the presence or absence of cerebral infarction. The location of cere-
bral infarction were divided into two territories of the cortical branch (cortical
infarction) or the territories of deep perforators (perforating infarction) to eval-
uate atherothrombotic or embolic cerebral infarction. Cortical and perforating
infarctions were found in 42% and 16”/0of all patients, respectively.
Results:
Cortical Infarction PerforatingInfarction
present absent present absent
n. 36 49 14 71
SEC (+) (“/4) 80.6” 52.1 65.7 60.0
IA thrombus(+) (“A) 57.1 36.8 57,1 44,3
LAA-F (cmJaec) 32.6 36.6 25,2 36.9
IMT of Aorta (mm) 1.9 1.7 3.3* 1.5
*P <0.05 va. correspondingvalues in each group
Multivariate Iogisficanalysis revealed that SEC was independent predictor
of embolic cortical infarction, while IMT of Aorta was useful in predicting the
riak of atherothrombotic perforating infarction.
